Record quarter masked by ₹46 Cr inventory gain; normalized earnings far softer

Revenue growth real; PAT growth 75% driven by ₹46.24 Cr one-time inventory gain, normalized PAT ~₹15.5 Cr

15.46% is genuine but unsustainable; management explicitly expects normalization to 7-10% range

Renewable share 40% of consumption; targeting 50% post H2 commissioning. Value unquantified but acknowledged positive

Matches delivered result; volume growth 12% YoY to 19,199 MT also aligns

Demand is robust but management can't quantify GST split; commodity imports from China at low prices remain pressure

Q1 FY27 benefited from ₹46.24 Cr one-time inventory gain on low-cost opening stock. Management expects this to reverse in coming quarters as higher-cost inventory is consumed; margin normalization explicitly flagged.

10.5 MW additional capacity planned (26% equity investment, ₹8.5 Cr capex). When commissioned in H2, renewable share to move 40% → 50%, targeting cost reduction per ton. No prior guidance had this quantum of capex.

Prior guidance (FY26 calls) was 7-10% EBITDA margins. Upgraded from 6-8% before that. This call: reaffirmed 7-10%, explicitly stated as 'normalized' and not to be breached. No upside surprise despite capex initiatives.

Investment in mother yarn (new WAP), customer-specific filament products to counter commodity imports. Year-over-year increasing but management won't disclose %. All projects have hurdle rate >12-15%, accretive to bottom line.

Approval process 'moving in desired direction'; commercial sales 'expected' in H2 FY27. No customer names, no order book, no volume guidance. Still pilot phase.

₹46.24 Cr disclosed in quarterly filings; reported per stock exchange norms, no further breakdown given

40% currently, targeting 50% after H2 commissioning; won't quantify rupee value but expect bottom-line improvement

Can't quantify; GST cut happened Sept 2025, ongoing since then; auto demand across all segments up quarter-on-quarter; geopolitical/crude volatility remain demand risks

Volume growth from GST boost is the offsetting factor; sharp cost moves drive inventory impact; gradual volatility doesn't move gross margin much

We upgraded from 6-8% already; will upgrade further once confident initiatives are working and won't breach lower bound; too early to guide higher

>₹100 Cr FY27; mother yarn capacity FY28 (+3-4k MT); value-add products; renewable power 10.5 MW (₹8.5 Cr equity); all projects targeted for 12-15% minimum IRR

Imported materials 25-30 days (incl. transit); domestic 10-15 days; sourcing from China, other countries, domestic suppliers; no availability risk foreseen

These drivers are positive but we won't guide higher until proven; will revise once confident we won't breach guidance on lower side; too many variables

Q1 FY27 volume 19,199 MT (vs 17,072 Q1 FY26, 20,711 Q4 FY26); can't guide forward realizations due to volatile pricing

Won't disclose exact numbers; all investments have hurdle rates >12-15%; accretive to bottom line; purpose is margin + volume protection vs China imports

Management refused forward-looking revenue statements, citing pricing volatility and geopolitical risks. Emphasized demand remains 'encouraging' but no targets provided.

Maintained (not upgraded) despite capex on value-add and renewable power. Implies current quarter's 15.46% is outlier. Management will revise 'once confident' initiatives deliver sustainable uplift, avoiding lower-side breach.

Specific allocation: 10.5 MW renewable at Bharuch (₹8.5 Cr equity), mother yarn capacity (FY28: +3-4k MT), value-add product lines. Post-Bharuch Feb 2025 incident, enhanced safety capex.

₹46.24 Cr inventory gain (75% of reported PAT) won't repeat. Q2 expected to show margin compression as higher-cost inventory consumed. Normalized PAT run-rate ~₹15-20 Cr/Qtr vs reported ₹61.7 Cr.

Caprolactam and chip prices volatile due to crude and geopolitical tensions (Iran war). While management has passed through increases, sharp moves can create timing mismatches. Chinese imports at low prices limit pricing power on commodity grades.

At 85-90% capacity utilization with no major capacity additions in FY27. PTCF project (approval phase) is only growth avenue. No new NTCF/filament capacity planned until FY28 mother yarn project (+3-4k MT). Demand outpacing supply could leave growth capped.

Polyester Tire Cord Fabric project key to FY27 growth narrative. Approval process 'moving in desired direction' but no revenue yet. Commercial sales 'expected' in H2 but no firm timeline, customer names, or order book disclosed. Delay risk material.

GST cuts (Sept 2025) drove strong auto demand across 2W/3W/HCV. But cuts are now ~9 months old; demand boost may be saturating. Analysts flagged risk of 'demand air pocketing' in Q2-Q3 when GST tailwind fades. Financing availability and economic growth are longer-term drivers.

Commodity filament yarn imported from China at very low prices. Finance Ministry did not notify anti-dumping duty despite DGTR approval. Pressure on commodity volumes and pricing. Management's mitigation: shift to value-add products, but this is still in progress and unquantified.